Opendata, web and dolomites
H2020 projects about "multidrug"
The page lists 46 projects related to the topic "multidrug".
| # | |||
|---|---|---|---|
| 1 | LimitMDR | Utilizing evolutionary interactions to limit multidrug resistance | 2015 |
| 2 | complexNMR | Structural Dynamics of Protein Complexes by Solid-State NMR | 2015 |
| 3 | Inflammafish | Cross-talk between inflammation and autophagy in tuberculosis | 2016 |
| 4 | b-lactams C-H activation | Discovery of novel β-lactam analogs oriented to control multidrug-resistant bacteria enabled by Pd-catalyzed C–H activation of aliphatic amines | 2015 |
| 5 | ACPNMR | Structural dynamics of acyl carrier protein complexes through combined solution and solid-state NMR | 2015 |
| 6 | MDR Tuberculosis | Evolution and success of the multi-drug resistant M. tuberculosis SIT41 (LAM7-TUR) lineage | 2015 |
| 7 | PROTOCOL | New processing technology for colistmethate sodium, leading to improved and cost-effective formulations for pharmaceutical and veterinary markets | 2015 |
| 8 | MARA | Molecular Analytical Robotics Assays | 2015 |
| 9 | PACEMech | The structure and molecular mechanism of transport proteins within the PACE family of multidrug efflux pumps | 2017 |
| 10 | PERSIST | Systematic identification of (p)ppGpp-dependent multidrug and stress tolerance factors | 2016 |
| 11 | RESOLVE | antibiotic RESistance and mObile genetic eLements dissemination in enVironmEntal conditions | 2016 |
| 12 | SUPRABIOTICS | Supramolecular Protective Groups Enabling Antibiotics and Bioimaging | 2016 |
| 13 | ALERT | Local Training Network on Novel Tailor-Made Antimicrobials and Delivery Strategies From Synthesis towards Clinical Applications | 2016 |
| 14 | HEAL-BY-MIRNA | microRNA replacement therapy for mature B cell neoplasias | 2016 |
| 15 | tagMDR | Identification of Multidrug Resistance for Chemotherapy Guidance in Cancer Using a Lab-on-a-chip Platform | 2016 |
| 16 | STRINGENCY | Control of Bacterial Multidrug Tolerance and Stress Response by Alarmone Synthetase SpoT | 2017 |
| 17 | anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept | 2017 |
| 18 | MDRZYMES | Multidrug resistance gene regulators as scaffolds for the design and evolution of artificial metalloenzymes | 2017 |
| 19 | ILTIS | Innate-Like T-Cells In Sepsis (ILTIS): Implications for Early Diagnosis and Rescue of Immune Suppression. | 2017 |
| 20 | CATRATS | Catalytic Enantioselective Allene Cycloisomerisation Reactions for Alkaloid Total Synthesis | 2017 |
| 21 | RESUSCITATION | Bacterial persister regrowth | 2018 |
| 22 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 23 | ChronosAntibiotics | Exploring the bacterial cell cycle to re-sensitize antibiotic-resistant bacteria | 2018 |
| 24 | ProphARG | Evolution of Prophages that carry Antibiotic Resistance Genes (ARGs) and their host-bacteria in response to antibiotics and increased lytic activity | 2018 |
| 25 | SaRNAReg | Staphylococcus aureus sRNA targetomes and regulatory networks involved in fast adaptive responses: structure, mechanisms and dynamics | 2018 |
| 26 | iCHEMGENODRUGS_TB | Chemogenomics and in silico repurposing as an innovative approach for rapid drug discovery in tuberculosis | 2018 |
| 27 | AMR-TB | Theoretical and computational investigation of tuberculosis antimicrobial resistance development based on extensive experimental library of mycobacterium strains | 2019 |
| 28 | kINPen | Developing a high-innovative portable cold plasma device for efficient healing of chronic wounds in veterinary medicine | 2019 |
| 29 | KryptonInt | Erasing the superintegron to understand the role of chromosomal integrons in bacterial evolution | 2019 |
| 30 | ESX-4 T7SS | Structure/function of a prototypic type VII secretion system from a fast-growing pathogenic mycobacteria | 2019 |
| 31 | TBNANO | Targeted intracellular delivery of antitubercular agents by functionalized nanocapsules | 2019 |
| 32 | POLAR STAR | Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer | 2019 |
| 33 | Host-TB | Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis | 2019 |
| 34 | RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors | 2019 |
| 35 | RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs | 2019 |
| 36 | RAID | Veterinary Decision Support System by Rapid Bacterial Infection Detection (RAID) | 2019 |
| 37 | TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | 2019 |
| 38 | ABOLED | Commercial feasibility of an anti-bacterial treatment | 2019 |
| 39 | LIGHT4LUNGS | Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections | 2019 |
| 40 | PAVax | A training network for the design of new synthetic carbohydrate-based vaccines to combat antibiotic resistant Pseudomonas aeruginosa | 2020 |
| 41 | DRTB-HDT | STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL | 2020 |
| 42 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
| 43 | PP-MAGIC | (Photo-)Control of Persisters: Targeting the Magic Spot | 2020 |
| 44 | mARs | mARs: Mobile DNA driven antibiotic resistance spreading: molecular strategies, control and evolution for broad distribution | 2021 |
| 45 | Absent Presences | Absent Presences: an ethnographic study of the uncounted lives of people affected by leprosy in Latin America | 2020 |
| 46 | BiLamVesicles | Novel bi-lamellar lipid vesicles for studying double-membrane transenvelope proteins | 2020 |